Recall of intravenous products due to lack of sterility assurance


The FDA report “Oregon Compounding Centers, Inc. issues voluntary recall of unexpired sterile products in Oregon and Washington due to lack of sterility assurance. Thet continue “The company has not received any reports of product contamination or adverse events to date, but is issuing this voluntary recall out of an abundance of caution following a recent inspection which identified an issue with sterility assurance. If there is microbial contamination in products intended to be sterile, patients are at risk of serious infections which may be life threatening.”

Click here for the list of drugs recalled.

Thank you to our partners for supporting IVTEAM


Comments are closed.